Exploratory study of blood metabolites altered by a single nucleotide polymorphism type (SNP-617)

Validation study of Nrf2 markers for blood metabolites - A single nucleotide polymorphism type (SNP-617) and blood metabolites

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051882

Enrollment

640

Registered

2023-08-10

Start date

2023-08-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Men and women aged 20 years and over who participated in the 2014-2017 Iwaki health promotion project and live in the Iwaki area of Hirosaki City, Aomori Prefecture.

Exclusion criteria

Exclusion criteria: 1) Those with missing SNP-617 data. 2) Subjects who are judged unsuitable for this trial by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Data collected during the annual Iwaki Health Promotion Project will be analyzed. The period is data from 2014 to 2017. The impact of SNP-617 on blood metabolites will be determined.	—

Secondary

Measure	Time frame
Exploratory analysis of the relationship between SNP-617 and other tests than blood metabolites.	—

Countries

Japan

Contacts

Public ContactKen Itoh

Hirosaki university Department of Stress Response Science, Graduate School of Medicine

Itohk@hirosaki-u.ac.jp0172-39-5157

Outcome results